PLANNING RESEARCH AND DEVELOPMENT OF NEW DRUGS TO ASSURE REGULATORY APPROVAL

被引：0
|
作者：
HURLEY, FL
机构：
来源：
FOOD AND DRUG LAW JOURNAL | 1984年 / 39卷 / 03期
关键词：
D O I：
暂无
中图分类号：
TS2 [食品工业];
学科分类号：
0832 ;
摘要：
引用
收藏
页码：312 / 317
页数：6
相关论文
共 50 条
  • [1] Clinical Development and Regulatory Approval of Acute Heart Failure Drugs in Japan
    Shinagawa, Kaori
    CARDIOVASCULAR DRUGS AND THERAPY, 2015, 29 (02) : 107 - 109
  • [2] The Regulatory Approval Process of Animal Drugs
    Stephen J. Gilbride
    Michael J. McGowan
    Drug information journal : DIJ / Drug Information Association, 1999, 33 (1): : 33 - 39
  • [3] The regulatory approval process of animal drugs
    Gilbride, SJ
    DRUG INFORMATION JOURNAL, 1999, 33 (01): : 33 - 39
  • [4] Analysis of new drugs whose clinical development and regulatory approval were hampered during their introduction in Japan
    Asada, R.
    Shimizu, S.
    Ono, S.
    Ito, T.
    Shimizu, A.
    Yamaguchi, T.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (04) : 309 - 313
  • [5] APPROVAL OF NEW DRUGS
    WIENER, H
    SCIENCE, 1973, 181 (4095) : 110 - &
  • [6] The Evolving Paradigm for Clinical Development and Regulatory Approval of Antiretroviral Drugs in the United States
    David M. Cocchetto
    Lynn Smiley
    Drug information journal : DIJ / Drug Information Association, 1999, 33 (2): : 357 - 372
  • [7] The evolving paradigm for clinical development and regulatory approval of antiretroviral drugs in the United States
    Cocchetto, DM
    Smiley, L
    DRUG INFORMATION JOURNAL, 1999, 33 (02): : 357 - 372
  • [8] Case studies with new excipients: development, implementation and regulatory approval
    Koo, Otilia M. Y.
    Varia, Sailesh A.
    THERAPEUTIC DELIVERY, 2011, 2 (07) : 949 - 956
  • [9] Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome
    Isaacsohn, JL
    Troendle, AJ
    Orloff, DG
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (11): : 49C - 52C
  • [10] Impact of the US Accelerated Approval for New Anticancer Drugs on Time to Verification of Benefit and Regulatory Approval in the EU and Japan
    Akira Ito
    Mamoru Narukawa
    Therapeutic Innovation & Regulatory Science, 2024, 58 : 136 - 142
12345